
Independent Medical Alliance Publishes Volume 2, No. 5 of Journal of Independent Medicine, Expanding Global Scientific Collaboration
The Independent Medical Alliance (IMA) has announced the publication of Volume 2, No. 5 of the Journal of Independent Medicine (JIM), marking another milestone in the organization’s efforts to promote independent scientific research, international medical collaboration and evidence-based discussions across diverse healthcare disciplines.
The latest issue continues the journal’s expanding international presence and brings together physicians, researchers and medical experts from different countries and clinical backgrounds. Featuring ten articles, the publication addresses a broad range of healthcare topics, including metabolic health, fasting and caloric restriction, cancer biology, COVID-19 public health policy, pharmacovigilance, vaccine regulatory science, cardiovascular pathology, dermatology, medical publishing and scientific freedom.
Through this collection of original investigations, narrative reviews and expert perspectives, the journal aims to provide a platform for researchers to examine complex medical questions, discuss emerging evidence and contribute to scientific conversations without commercial or political influences.
The publication reflects IMA’s broader mission of advancing what it describes as independent medicine through transparent scientific inquiry and collaboration among healthcare professionals. As medical research becomes increasingly interconnected across countries and healthcare systems, the organization emphasizes the importance of allowing researchers from different specialties and geographical regions to share observations, challenge established assumptions and contribute evidence to ongoing medical discussions.
The latest issue also highlights the importance of examining healthcare challenges from multiple perspectives, particularly in areas where scientific evidence, regulatory decisions and public health policies continue to generate discussion.
Journal Expands Its International Scientific Community
The publication of Volume 2, No. 5 represents another step in the development of the Journal of Independent Medicine as an international platform for scientific research and medical discourse.
The journal brings together contributions from researchers working across multiple medical specialties, creating opportunities to examine healthcare issues that extend beyond national boundaries. Its articles cover subjects ranging from individual patient care and disease mechanisms to broader questions involving regulatory science, public health policy and the communication of medical evidence.
Joseph Varon, MD, Editor-in-Chief of the Journal of Independent Medicine and President and Chief Medical Officer of the Independent Medical Alliance, emphasized the importance of international scientific collaboration in advancing medicine.
“Medicine has always advanced when physicians and scientists learn from one another, and today that conversation must be global,” Varon said.
He explained that the challenges affecting patients are not restricted by geographical boundaries and that scientific research should similarly encourage international participation and collaboration.
According to Varon, as IMA continues to strengthen its international relationships, the journal provides researchers and healthcare professionals from different countries, specialties and clinical environments with an opportunity to bring their observations and research into a shared scientific discussion.
He also highlighted the importance of maintaining evidence, transparency and a commitment to patient interests as central principles guiding these conversations.
The journal’s international focus is intended to encourage broader participation in medical research while providing a publication platform for professionals seeking to contribute perspectives from different clinical and scientific backgrounds.
Featured Investigation Examines FDA Clinical Data for Moderna’s mFLUSIVA Vaccine
One of the featured original investigations in Volume 2, No. 5 is titled “Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010).” The article was authored by Nicolas Hulscher, Peter A. McCullough, MD, and John A. Catanzaro.
The publication examines regulatory and clinical trial data associated with Moderna’s mRNA influenza vaccine, mFLUSIVA (mRNA-1010). The authors undertake a reanalysis of available FDA clinical data, focusing on absolute benefit-risk measurements to assess the vaccine’s reported efficacy, adverse events and supporting clinical evidence.
The investigation evaluates different aspects of the vaccine’s clinical and regulatory profile, including the magnitude of potential benefits and the frequency and nature of reported adverse events.
The authors question the overall benefit-risk profile of the vaccine and argue that their findings warrant additional scrutiny of its continued licensure.
The article contributes to the broader regulatory science discussion by examining how clinical trial findings and absolute benefit-risk measurements can inform evaluations of medical products.
Benefit-risk assessment is an important component of vaccine and pharmaceutical regulatory decision-making. It involves evaluating the potential clinical benefits of an intervention alongside its possible risks, considering factors such as the target population, disease burden, treatment effectiveness and safety findings.
The authors’ analysis represents their interpretation of the available data and is presented as part of the journal’s broader effort to encourage examination and discussion of regulatory evidence.
The article is among the issue’s notable contributions because of its focus on vaccine evaluation, clinical trial interpretation and the scientific basis for regulatory decisions.
IMA Emphasizes Scientific Independence and Open Discussion
Beyond the individual research topics, Volume 2, No. 5 reinforces an important principle underlying IMA’s approach to independent medicine: scientific independence should encourage collaboration rather than isolation.
According to the organization, independent scientific inquiry should provide researchers with opportunities to examine evidence, question established assumptions and discuss findings openly, regardless of their professional backgrounds or institutional affiliations.
Varon further emphasized this philosophy, stating that scientific independence should expand the conversation rather than narrow it.
He explained that when researchers with different perspectives can examine evidence openly, challenge assumptions and publish findings without commercial or political pressure, the scientific process can become stronger.
Varon described this approach as central to the organization’s concept of “Honest Medicine” and its objective of building an international scientific community through the journal.
The publication’s multidisciplinary structure reflects this approach by bringing together research and commentary addressing different aspects of healthcare. Rather than concentrating on a single therapeutic area, the latest issue covers a range of topics that influence medical research, clinical practice, regulatory decisions and patient care.
Ten Articles Cover a Broad Range of Medical and Scientific Topics
Volume 2, No. 5 includes ten articles contributed by physicians, researchers and subject-matter experts. The articles examine clinical research, disease mechanisms, public health questions, medical communication and the interpretation of scientific evidence.
The featured contributions include the following:
1. How to Write a Medical Manuscript That Gets Published: A Practical Guide from the Editors’ Desk
Authors: Joseph Varon and Adylle T. Varon
This article provides practical guidance for physicians and researchers seeking to publish their medical research in scientific journals.
Written by Journal of Independent Medicine editors Joseph Varon and Adylle T. Varon, the guide examines important considerations involved in preparing and submitting medical manuscripts.
The article addresses topic selection, manuscript organization, journal selection and the peer-review process. It aims to help researchers understand the essential components of scientific writing and improve their ability to communicate research findings effectively.
Medical publishing plays an important role in disseminating clinical observations and research results. By providing guidance on manuscript preparation, the article seeks to support physicians and researchers interested in contributing to the scientific literature.
2. From Autophagy to Clinical Practice: Fasting and Caloric Restriction
Authors: Francesca Martinez-Nachon, Mariel Coronel, Luciana B. Suntanto and Joseph Varon
This narrative review examines fasting and caloric restriction, focusing on their potential biological mechanisms and relevance to metabolic health.
The authors discuss autophagy, a cellular process involved in breaking down and recycling damaged or unnecessary cellular components. The review explores how fasting-related metabolic changes may influence this process and examines the available human evidence.
The article also considers practical nutritional factors that may influence adherence to fasting approaches, including protein intake, dietary fiber, hydration and ketone production.
By connecting biological mechanisms with clinical considerations, the review provides an overview of the scientific questions surrounding fasting and caloric restriction.
3. A Narrative Review of COVID-19 Public Health Literature Critical of the Mainstream Narrative
Author: Marco Chiesa
This article reviews published literature examining perspectives that challenge aspects of the widely accepted COVID-19 public health narrative.
Written by Dr. Marco Chiesa, the review discusses research and commentary addressing several areas of the pandemic response, including viral origins, disease lethality, early treatment approaches and lockdown policies.
The article examines differing interpretations of the available literature and contributes to ongoing discussions concerning pandemic research, public health interventions and the evaluation of scientific evidence.
The subject remains relevant to medical and public health research because understanding the effectiveness and limitations of pandemic responses is important for informing future healthcare preparedness and policy development.
4. Topical Melatonin in Androgenetic Alopecia: Mechanisms of Action and Current Clinical Evidence
Authors: Scarlet Raquel Ahumada-Félix, Francisco Javier Castro-Apodaca, Dalia Magaña-Ordorica, Joel Murillo-Llanes and Martha Leticia Gomez-Martinez
This narrative review explores the potential application of topical melatonin in androgenetic alopecia, a common form of hair loss affecting men and women.
The authors examine proposed biological mechanisms through which topical melatonin may influence hair follicle activity.
The review discusses its potential antioxidant and anti-androgen effects, along with possible influences on the anagen phase, which represents the active growth stage of the hair cycle.
The article also evaluates currently available clinical evidence concerning topical melatonin and its potential role in hair loss management.
5. The Global Decline of Human Body Temperature: Evidence for a Metabolic and Immunological Crisis
Author: Matthew Cormier
This review examines reported changes in average human body temperature over approximately the past century and explores possible connections with metabolic and immune health.
Matthew Cormier discusses the historical decline in average human body temperature and considers potential relationships with chronic illness, immune function and metabolic changes.
The article presents the author’s perspective on whether these trends may reflect broader changes in human physiology and population health.
The subject provides an opportunity to examine historical physiological measurements and their potential implications for understanding changes in health across populations.
6. Rising Anemia Rates Amidst the COVID-19 Pandemic: Is There a Connection?
Authors: Francesca Martinez-Nachon, Alan Araiza, Jose Iglesias and Joseph Varon
This retrospective cohort study examines anemia trends during the COVID-19 pandemic using a large U.S. inpatient dataset involving approximately 136 million hospitalizations.
The researchers investigate changes in anemia rates during the pandemic period and assess whether COVID-19 itself was a major contributing factor.
According to the article’s reported findings, anemia rates increased during the pandemic, although COVID-19 infection itself was not identified as a major driver of the observed trend.
The study contributes to discussions about changes in inpatient health conditions during the pandemic and highlights the importance of evaluating broader healthcare and population-level factors when interpreting disease trends.
7. Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010)
Authors: Nicolas Hulscher, Peter A. McCullough and John A. Catanzaro
This original investigation reexamines FDA clinical trial data associated with Moderna’s mFLUSIVA (mRNA-1010) influenza vaccine.
The authors use absolute benefit-risk measures to assess clinical efficacy, adverse events and the available regulatory evidence.
Their analysis reports what they characterize as minimal absolute benefit, high reactogenicity and a mortality signal. Based on their interpretation, the authors argue that the findings warrant additional scrutiny of the vaccine’s benefit-risk profile and continued licensure.
The article contributes to discussions surrounding vaccine clinical trial analysis, safety evaluation and regulatory decision-making. Its conclusions represent the authors’ interpretation and require consideration alongside the complete clinical and regulatory evidence.
8. Convergent Evidence for a Distinct Intravascular Matrix: Integrated Morphological, Elemental, and Proteomic Analysis of Anomalous Intravascular Casts
Authors: Bruce Rapley and Matt Shelton
This investigation examines anomalous intravascular casts using multiple analytical approaches, including histological examination, elemental analysis through inductively coupled plasma mass spectrometry (ICP-MS) and proteomic analysis.
The researchers investigate the morphological, elemental and protein characteristics of the examined materials.
According to the authors, the combined findings indicate a distinct fibrin matrix that differs from ordinary blood clots.
By integrating different laboratory techniques, the study seeks to provide additional information about the composition and structural characteristics of the analyzed intravascular materials.
9. Integrative Cancer Therapies Addressing Tumoral Metabolic Pathways
Authors: John G. Ionescu and Alexandru Tudor Constantinescu
This review explores tumor metabolism and discusses potential therapeutic approaches targeting metabolic pathways associated with cancer biology.
Drs. John G. Ionescu and Alexandru Tudor Constantinescu examine several biological mechanisms, including redox regulation, alkalinization and the Warburg effect.
The Warburg effect describes the tendency of many cancer cells to rely heavily on glycolysis for energy production, even when oxygen is available.
The article considers how these metabolic characteristics may influence tumor development and discusses integrative approaches proposed to target aspects of tumor metabolism.
The review contributes to broader scientific discussions about cancer cell biology and the investigation of metabolic processes as potential therapeutic targets.
10. Medical Censorship and the Erosion of Scientific Discourse: Patients and Doctors Must Navigate Bias in an Era of Suppressed Debate
Authors: Mitchell B. Liester and Robert Enzenauer
This perspective article examines concerns surrounding medical censorship, professional debate and the communication of scientific information.
Drs. Mitchell B. Liester and Robert Enzenauer discuss issues involving professional oversight, board decertification and potential barriers to open medical discussion.
The authors also consider how patients and healthcare professionals can navigate information bias and differing interpretations of medical evidence.
The article emphasizes the importance of scientific communication and the ability of medical professionals to engage in discussions about clinical research, healthcare policies and treatment approaches.
Strengthening Medical Research and Scientific Publishing
The publication of Volume 2, No. 5 highlights the Journal of Independent Medicine’s commitment to covering a wide range of scientific and clinical subjects through contributions from international researchers.
The ten articles demonstrate the journal’s multidisciplinary approach, bringing together original investigations, narrative reviews and expert perspectives. Topics range from metabolic health and dermatology to cancer biology, vaccine regulatory science, cardiovascular pathology and medical publishing.
The issue also highlights the importance of scientific communication in healthcare. Medical progress depends not only on conducting research but also on ensuring that findings are effectively communicated, critically evaluated and discussed within the broader scientific community.
Through its international network of contributors, IMA aims to provide a platform where researchers and clinicians can share their work and engage in discussions about complex medical challenges.
Access to the Latest Journal Issue
The Independent Medical Alliance expressed its appreciation to the physicians, researchers and contributors involved in developing the latest issue and supporting the journal’s continued growth.
Volume 2, No. 5, along with previous issues of the Journal of Independent Medicine, is available through the journal’s official website at JournalofIndependentMedicine.org.
With its latest publication, IMA continues its efforts to expand international scientific collaboration and encourage open discussion across medical specialties. By bringing together research on clinical practice, public health, regulatory science and scientific publishing, the journal aims to contribute to a broader exchange of medical knowledge and perspectives.
The organization expects its growing international scientific community to remain an important part of the journal’s development, supporting its mission of advancing independent inquiry, transparency and patient-focused medical research.
About the Journal of Independent Medicine
The Journal of Independent Medicine, published by the Independent Medical Alliance™, is a double-blind peer-reviewed, multi-specialty medical journal dedicated to advancing transparent, evidence-based, and conflict-free scientific inquiry. The journal provides a platform for rigorous clinical research, medical ethics, health policy, and open scientific discussion across a broad range of disciplines. Learn more at www.JIndepMed.org.
About the Independent Medical Alliance
The Independent Medical Alliance™ is a nonprofit 501(c)(3) and global coalition of physicians, scientists, and healthcare professionals working to restore transparency, informed consent, patient trust, and Honest Medicine™ across the profession and within government health agencies. The IMA is working to protect patients and doctors from corporate capture and one-size-fits-all mandates that limit individualized care, and the IMA believes long-term wellness and disease prevention is essential to effective medicine. Grounded in evidence-based medicine and systemic reform, the IMA is working in the US and abroad to build a more compassionate and effective healthcare system.



